3don MSN
Shapiro visits Philly to debut $125 million investment in Pennsylvania’s life sciences industry
Gov. Josh Shapiro visited a University City life sciences incubator on Tuesday to celebrate a new $125 million fund aimed at ...
MJH Life Sciences® has been named a New Jersey Top Workplaces 2026 winner by NJ Advance Media, based on a confidential employee survey administered by Energage LLC. The recognition affirms what the ...
Pharmaceutical Technology on MSN
Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory
BMS enhances its AI computing power as big pharma race to stay competitive within the shifting global landscape.
Large language models (LLMs) are gradually transforming research in the life sciences in ways that extend far beyond ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Frazier Life Sciences (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the closing of Frazier Life Sciences XII, L.P. (FLS ...
At an event for pharmaceutical executives, biotech founders, and researchers on Tuesday, Anthropic announced Claude Science, a major new product intended to support scientific research in the same way ...
Creative Life Science Advances PIC/S GMP-Compliant Cell Therapy Materials and Manufacturing Platform
Creative Life Science (7837) is showcasing its upstream regenerative medicine materials, process-development capabilities and quality-testing services, highlighting the build-out and service capacity ...
In this week’s edition of InnovationRx, we look at cancer breakthroughs from the ASCO conference, Clear’s move into healthcare, Harrison.ai’s U.S. expansion, and more. To get it in your inbox, ...
CDT. Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics. ITASCA, IL, US and HU ...
Wave Life Sciences has seen its share price fall 64.0% year to date, yet the valuation checks suggest the stock still screens as expensive rather than a clear bargain. Wave Life Sciences is down 64.0% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results